Sun H - Search Results

1

Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.

Yang Y, Zhang J, Zhu Y, Zhang Z, Sun H, Feng Y. Yang Y, et al. Among authors: sun h. Int J Gynecol Cancer. 2014 Nov;24(9):1564-74. doi: 10.1097/IGC.0000000000000279. Int J Gynecol Cancer. 2014. PMID: 25340291

2

[Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].

Zhang PN, Sun H. Zhang PN, et al. Among authors: sun h. Zhonghua Fu Chan Ke Za Zhi. 2007 Mar;42(3):196-200. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17537308 Chinese.

3

Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer.

Zhang XY, Zhang HY, Zhang PN, Lu X, Sun H. Zhang XY, et al. Among authors: sun h. Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):237-44. doi: 10.1016/j.ejogrb.2007.12.021. Epub 2008 Apr 18. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 18395956

4

[Preparation and in vitro targeting of follicle stimulating hormone polypeptide modified nanoparticles].

Zhang XY, Chen J, Gao XL, Sun H, Xu CJ. Zhang XY, et al. Among authors: sun h. Zhonghua Fu Chan Ke Za Zhi. 2008 Jul;43(7):533-7. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19080519 Chinese.

5

Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.

Zhang HY, Zhang PN, Sun H. Zhang HY, et al. Among authors: sun h. Eur J Obstet Gynecol Reprod Biol. 2009 Sep;146(1):81-6. doi: 10.1016/j.ejogrb.2009.04.035. Epub 2009 Jun 21. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19540648

6

Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer.

Zhang HY, Sun H. Zhang HY, et al. Among authors: sun h. Cancer Lett. 2010 Jan 1;287(1):91-7. doi: 10.1016/j.canlet.2009.06.001. Epub 2009 Jul 22. Cancer Lett. 2010. PMID: 19628330

7

Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.

Zhang XY, Chen J, Zheng YF, Gao XL, Kang Y, Liu JC, Cheng MJ, Sun H, Xu CJ. Zhang XY, et al. Among authors: sun h. Cancer Res. 2009 Aug 15;69(16):6506-14. doi: 10.1158/0008-5472.CAN-08-4721. Epub 2009 Jul 28. Cancer Res. 2009. PMID: 19638590

8

Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells.

Zhu J, Hua K, Sun H, Yu Y, Jin H, Feng Y. Zhu J, et al. Among authors: sun h. Oncol Rep. 2011 Dec;26(6):1497-503. doi: 10.3892/or.2011.1430. Epub 2011 Aug 24. Oncol Rep. 2011. PMID: 21874257

9

Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression.

Zhu J, Lu X, Hua KQ, Sun H, Yu YH, Feng YJ. Zhu J, et al. Among authors: sun h. Arch Gynecol Obstet. 2012 Sep;286(3):729-37. doi: 10.1007/s00404-012-2368-5. Epub 2012 May 9. Arch Gynecol Obstet. 2012. PMID: 22569715

10

Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.

Zhang P, Zhang P, Zhou M, Jiang H, Zhang H, Shi B, Pan X, Gao H, Sun H, Li Z. Zhang P, et al. Among authors: sun h. Carcinogenesis. 2013 Nov;34(11):2639-46. doi: 10.1093/carcin/bgt216. Epub 2013 Jun 12. Carcinogenesis. 2013. PMID: 23764753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,837 results

Search Page

Filters